Search Results

There are 1869 results for: content related to: Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Version of Record online : 18 OCT 2013, DOI: 10.1002/pds.3539

  3. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Version of Record online : 27 MAY 2011, DOI: 10.1002/pds.2153

  4. Incidence of tramadol shopping behavior in a retrospective cohort of chronic non-cancer pain patients in France

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 9, September 2016, Pages: 1088–1098, Chouki Chenaf, Jean-Luc Kabore, Jessica Delorme, Bruno Pereira, Aurélien Mulliez, Lucie Roche, Alain Eschalier, Noémie Delage and Nicolas Authier

    Version of Record online : 30 JUN 2016, DOI: 10.1002/pds.4056

  5. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Version of Record online : 13 MAY 2014, DOI: 10.1002/pds.3636

  6. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 238–250, Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Version of Record online : 2 NOV 2015, DOI: 10.1002/pds.3880

  7. Persistence of racial disparities in prescription of first-generation antipsychotics in the USA

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 11, November 2015, Pages: 1197–1206, Thomas B. Cook, Gloria M. Reeves, James Teufel and Teodor T. Postolache

    Version of Record online : 1 JUL 2015, DOI: 10.1002/pds.3819

  8. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  9. Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 785–796, Kristian B. Filion, Lawrence Joseph, Jean-François Boivin, Samy Suissa and James M. Brophy

    Version of Record online : 13 JUN 2011, DOI: 10.1002/pds.2165

  10. The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug–drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly

    Pharmacoepidemiology and Drug Safety

    Volume 26, Issue 7, July 2017, Pages: 752–765, Muh. Akbar Bahar, Eelko Hak, Jens H.J. Bos, Sander D. Borgsteede and Bob Wilffert

    Version of Record online : 26 MAR 2017, DOI: 10.1002/pds.4200

  11. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Version of Record online : 29 MAR 2011, DOI: 10.1002/pds.2136

  12. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  13. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  14. You have free access to this content
    Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue S1, March 2016, Pages: 132–141, Md. Jamal Uddin, Rolf H. H. Groenwold, Anthonius de Boer, Ana S. M. Afonso, Paola Primatesta, Claudia Becker, Svetlana V. Belitser, Arno W. Hoes, Kit C. B. Roes and Olaf H. Klungel

    Version of Record online : 1 APR 2016, DOI: 10.1002/pds.3860

  15. Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 1, January 2016, Pages: 26–34, Mehmet Burcu, Daniel J. Safer and Julie M. Zito

    Version of Record online : 28 OCT 2015, DOI: 10.1002/pds.3897

  16. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 4, April 2015, Pages: 435–445, Mir M. Ali, Catherine E. O'Brien, Mario A. Cleves and Bradley C. Martin

    Version of Record online : 12 FEB 2015, DOI: 10.1002/pds.3758

  17. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Version of Record online : 6 JUN 2012, DOI: 10.1002/pds.3291

  18. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 7, July 2012, Pages: 697–709, Jeremy A. Rassen, Robert J. Glynn, Kenneth J. Rothman, Soko Setoguchi and Sebastian Schneeweiss

    Version of Record online : 8 DEC 2011, DOI: 10.1002/pds.2256

  19. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1202–1215, Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

    Version of Record online : 4 JUL 2012, DOI: 10.1002/pds.3318

  20. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1155–1172, Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

    Version of Record online : 9 AUG 2012, DOI: 10.1002/pds.3329